Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Perturbation of microRNAs in Rat Heart during Chronic Doxorubicin Treatment

  • Caterina Vacchi-Suzzi,

    Affiliation Discovery and Investigative Safety, Novartis Institutes for Biomedical Research, Basel, Switzerland

  • Yasmina Bauer,

    Affiliation Translational Science Biology, Actelion Pharmaceuticals Ltd, Allschwil, Switzerland

  • Brian R. Berridge,

    Affiliation Safety Assessment, GlaxoSmithKline, Research Triangle Park, North Carolina, United States of America

  • Sandrine Bongiovanni,

    Affiliation Biomarker Development, Novartis Institutes for Biomedical Research, Basel, Switzerland

  • Kevin Gerrish,

    Affiliation National Institute of Environmental Health Science, National Institutes of Health, Research Triangle Park, North Carolina, United States of America

  • Hisham K. Hamadeh,

    Affiliation Comparative Biology and Safety Sciences, Amgen Inc., Thousand Oaks, California, United States of America

  • Martin Letzkus,

    Affiliation Biomarker Development, Novartis Institutes for Biomedical Research, Basel, Switzerland

  • Jonathan Lyon,

    Affiliation Investigative Preclinical Toxicology, GlaxoSmithKline, Ware, United Kingdom

  • Jonathan Moggs,

    Affiliation Discovery and Investigative Safety, Novartis Institutes for Biomedical Research, Basel, Switzerland

  • Richard S. Paules,

    Affiliation National Institute of Environmental Health Science, National Institutes of Health, Research Triangle Park, North Carolina, United States of America

  • François Pognan,

    Affiliation Discovery and Investigative Safety, Novartis Institutes for Biomedical Research, Basel, Switzerland

  • Frank Staedtler,

    Affiliation Biomarker Development, Novartis Institutes for Biomedical Research, Basel, Switzerland

  • Martin P. Vidgeon-Hart,

    Affiliation Investigative Preclinical Toxicology, GlaxoSmithKline, Ware, United Kingdom

  • Olivier Grenet,

    Affiliation Discovery and Investigative Safety, Novartis Institutes for Biomedical Research, Basel, Switzerland

  • Philippe Couttet

    philippe.couttet@novartis.com

    Affiliation Discovery and Investigative Safety, Novartis Institutes for Biomedical Research, Basel, Switzerland

Viewed

Cited

Saved

Discussed

Powered by Altmetric
Questions or concerns about usage data? Please let us know.